| Primary |
| Ischaemic Heart Disease Prophylaxis |
38.8% |
| Atrial Fibrillation |
7.2% |
| Product Used For Unknown Indication |
5.8% |
| Arthritis |
5.0% |
| Hypertension |
5.0% |
| Myocardial Infarct Prophylaxis |
5.0% |
| Cerebrovascular Accident Prophylaxis |
3.6% |
| Anticoagulant Therapy |
2.9% |
| Arthralgia |
2.9% |
| Back Pain |
2.9% |
| Prophylaxis |
2.9% |
| Rehabilitation Therapy |
2.9% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Myocardial Infarction |
2.2% |
| Pain |
2.2% |
| Tia |
2.2% |
| Agitation |
1.4% |
| Arthropathy |
1.4% |
| Asthma |
1.4% |
|
| Macular Degeneration |
10.8% |
| Off Label Use |
10.8% |
| Haemorrhage |
9.2% |
| Rectal Haemorrhage |
7.7% |
| Ulcer |
7.7% |
| Gastric Haemorrhage |
6.2% |
| Faeces Discoloured |
4.6% |
| Tinnitus |
4.6% |
| Vaginal Haemorrhage |
4.6% |
| Age-related Macular Degeneration |
3.1% |
| Coeliac Disease |
3.1% |
| Death |
3.1% |
| Epistaxis |
3.1% |
| Gastric Ulcer |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Haematochezia |
3.1% |
| Haemorrhage Subcutaneous |
3.1% |
| Melaena |
3.1% |
| Post Procedural Haemorrhage |
3.1% |
| Skin Haemorrhage |
3.1% |
|
| Secondary |
| Ischaemic Heart Disease Prophylaxis |
31.0% |
| Arthritis |
16.3% |
| Back Pain |
6.2% |
| Cerebrovascular Accident Prophylaxis |
5.4% |
| Anticoagulant Therapy |
4.7% |
| Myocardial Infarct Prophylaxis |
4.7% |
| Analgesic Therapy |
3.9% |
| Prophylaxis |
3.9% |
| Atrial Fibrillation |
3.1% |
| Coronary Artery Disease |
3.1% |
| Pain |
3.1% |
| Headache |
2.3% |
| Arthralgia |
1.6% |
| Blood Cholesterol Abnormal |
1.6% |
| Cardiac Disorder |
1.6% |
| Coagulopathy |
1.6% |
| Hypertension |
1.6% |
| Malaise |
1.6% |
| Myocardial Infarction |
1.6% |
| Suicide Attempt |
1.6% |
|
| Off Label Use |
23.0% |
| Drug Ineffective |
13.1% |
| Incorrect Drug Administration Duration |
13.1% |
| Epistaxis |
4.9% |
| Myocardial Infarction |
4.9% |
| Tinnitus |
4.9% |
| No Adverse Event |
3.3% |
| Rectal Haemorrhage |
3.3% |
| Scar |
3.3% |
| Therapeutic Response Unexpected |
3.3% |
| Throat Irritation |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Vomiting |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Abdominal Pain Upper |
1.6% |
| Contusion |
1.6% |
| Disorientation |
1.6% |
| Drug Effect Incomplete |
1.6% |
| Eye Haemorrhage |
1.6% |
| Feeling Abnormal |
1.6% |
|
| Concomitant |
| Ischaemic Heart Disease Prophylaxis |
25.8% |
| Arthritis |
24.9% |
| Back Pain |
13.5% |
| Analgesic Therapy |
9.6% |
| Myocardial Infarct Prophylaxis |
4.4% |
| Myalgia |
2.2% |
| Nasopharyngitis |
2.2% |
| Pain |
2.2% |
| Sleep Disorder Therapy |
2.2% |
| Constipation |
1.7% |
| Ms |
1.7% |
| Arthralgia |
1.3% |
| Diuretic Therapy |
1.3% |
| Headache |
1.3% |
| Vitamin Supplementation |
1.3% |
| Back Ache |
0.9% |
| Cardiac Disorder Prophylaxis |
0.9% |
| Cerebrovascular Accident Prophylaxis |
0.9% |
| Diarrhoea |
0.9% |
| Dyspepsia |
0.9% |
|
| Incorrect Drug Administration Duration |
38.0% |
| Drug Ineffective |
14.0% |
| Incorrect Dose Administered |
6.2% |
| No Adverse Event |
4.7% |
| Off Label Use |
4.7% |
| Overdose |
4.7% |
| Somnolence |
3.1% |
| Throat Irritation |
3.1% |
| Blood Pressure Increased |
2.3% |
| Extra Dose Administered |
2.3% |
| Local Swelling |
2.3% |
| Therapeutic Response Unexpected |
2.3% |
| Abdominal Discomfort |
1.6% |
| Age-related Macular Degeneration |
1.6% |
| Arthritis |
1.6% |
| Diarrhoea |
1.6% |
| Dyspepsia |
1.6% |
| Pain |
1.6% |
| Pruritus |
1.6% |
| Pruritus Generalised |
1.6% |
|
| Interacting |
| Ischaemic Heart Disease Prophylaxis |
66.7% |
| Atrial Fibrillation |
11.1% |
| Neuralgia |
11.1% |
| Testicular Disorder |
11.1% |
|
| Labelled Drug-drug Interaction Medication Error |
33.3% |
| Rectal Haemorrhage |
33.3% |
| Urinary Tract Infection Enterococcal |
33.3% |
|
